We had the pleasure of speaking with Maria-Victoria Mateos, MD, PhD, to discuss the FDA approval of the subcutaneous daratumumab formulation in multiple myeloma.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
